Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fertisera
- Development stage
- Unknown
- Lead developer
- MMC Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fertisera is a combination pharmaceutical product developed and marketed by MMC Pharmaceuticals, specifically designed for the management of female infertility and gynecological health. It is primarily indicated for women with diminished ovarian reserve (DOR) or those identified as poor ovarian responders (POR) undergoing assisted reproductive technology (ART) procedures such as IVF. The formulation typically consists of micronized Dehydroepiandrosterone (DHEA) in a sustained-release form, Melatonin, and Folic Acid. DHEA acts as a pro-hormone precursor to intracellular androgens and estrogens, which are critical for early follicular recruitment and improving oocyte quality. Melatonin serves as a potent antioxidant within the follicular microenvironment, protecting developing oocytes from oxidative stress-induced damage. Folic Acid is included to support DNA synthesis and cellular division, while also providing essential periconceptional prophylaxis against neural tube defects.
- Brand names
- Fertisera
02
Targets
MTNR1A (MT1)DHFR (Dihydrofolate reductase)ER (Estrogen receptor)AR (Adrenergic receptors)
Beyond the preview
Go deeper on Fertisera.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fertisera.